These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 18795327)
1. Clinical implications and prognostic value of EMMPRIN/CD147 and MMP2 expression in pediatric gliomas. Gu J; Zhang C; Chen R; Pan J; Wang Y; Ming M; Gui W; Wang D Eur J Pediatr; 2009 Jun; 168(6):705-10. PubMed ID: 18795327 [TBL] [Abstract][Full Text] [Related]
2. Expression of emmprin (CD147), a cell surface inducer of matrix metalloproteinases, in normal human brain and gliomas. Sameshima T; Nabeshima K; Toole BP; Yokogami K; Okada Y; Goya T; Koono M; Wakisaka S Int J Cancer; 2000 Oct; 88(1):21-7. PubMed ID: 10962435 [TBL] [Abstract][Full Text] [Related]
3. EMMPRIN is an independent negative prognostic factor for patients with astrocytic glioma. Tian L; Zhang Y; Chen Y; Cai M; Dong H; Xiong L PLoS One; 2013; 8(3):e58069. PubMed ID: 23516431 [TBL] [Abstract][Full Text] [Related]
4. EMMPRIN expression positively correlates with WHO grades of astrocytomas and meningiomas. Tsai WC; Chen Y; Huang LC; Lee HS; Ma HI; Huang SM; Sytwu HK; Hueng DY J Neurooncol; 2013 Sep; 114(3):281-90. PubMed ID: 23817808 [TBL] [Abstract][Full Text] [Related]
5. Glioma cell extracellular matrix metalloproteinase inducer (EMMPRIN) (CD147) stimulates production of membrane-type matrix metalloproteinases and activated gelatinase A in co-cultures with brain-derived fibroblasts. Sameshima T; Nabeshima K; Toole BP; Yokogami K; Okada Y; Goya T; Koono M; Wakisaka S Cancer Lett; 2000 Sep; 157(2):177-84. PubMed ID: 10936678 [TBL] [Abstract][Full Text] [Related]
6. EMMPRIN expression is associated with metastatic progression in osteosarcoma. Kim HS; Kim HJ; Lee MR; Han I BMC Cancer; 2021 Sep; 21(1):1059. PubMed ID: 34565336 [TBL] [Abstract][Full Text] [Related]
7. Extracellular matrix metalloproteinase inducer is a negative prognostic factor of pediatric medulloblastoma. Chu T; Chen X; Yu J; Xiao J; Fu Z Pathol Oncol Res; 2011 Sep; 17(3):705-11. PubMed ID: 21448785 [TBL] [Abstract][Full Text] [Related]
8. The role of extracellular matrix metalloproteinase inducer glycosylation in regulating matrix metalloproteinases in periodontitis. Zhang Z; Yang X; Zhang H; Liu X; Pan S; Li C J Periodontal Res; 2018 Jun; 53(3):391-402. PubMed ID: 29315565 [TBL] [Abstract][Full Text] [Related]
9. EMMPRIN co-expressed with matrix metalloproteinases predicts poor prognosis in patients with osteosarcoma. Futamura N; Nishida Y; Urakawa H; Kozawa E; Ikuta K; Hamada S; Ishiguro N Tumour Biol; 2014 Jun; 35(6):5159-65. PubMed ID: 24481662 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of EMMPRIN and MMP-2 in the prognosis of primary cutaneous malignant melanoma. Chen T; Zhu J Med Oncol; 2010 Dec; 27(4):1185-91. PubMed ID: 19921476 [TBL] [Abstract][Full Text] [Related]
11. Gelatinase A, membrane type 1 matrix metalloproteinase, and extracellular matrix metalloproteinase inducer mRNA expression: correlation with invasive growth of breast cancer. Dalberg K; Eriksson E; Enberg U; Kjellman M; Bäckdahl M World J Surg; 2000 Mar; 24(3):334-40. PubMed ID: 10658069 [TBL] [Abstract][Full Text] [Related]
12. Extracellular matrix metalloproteinase inducer: a novel poor prognostic marker for human seminomas. Bi XC; Liu JM; He HC; Ye YK; Han ZD; Dai QS; Liang YX; Cai C; Chen JH; Chen XB; Qin GQ; Zeng GH; Zhong WD Clin Transl Oncol; 2012 Mar; 14(3):190-6. PubMed ID: 22374422 [TBL] [Abstract][Full Text] [Related]
13. Highly expressed tumoral emmprin and stromal CD73 predict a poor prognosis for external auditory canal carcinoma. Miyazaki M; Aoki M; Okado Y; Koga K; Hamasaki M; Nakagawa T; Sakata T; Nabeshima K Cancer Sci; 2020 Aug; 111(8):3045-3056. PubMed ID: 32473077 [TBL] [Abstract][Full Text] [Related]
14. Extracellular matrix metalloproteinase inducer (EMMPRIN) and matrix metalloproteinases (MMPs) as regulators of tumor-host interaction in a spontaneous metastasis model in rats. Donadio AC; Remedi MM; Susperreguy S; Frede S; Gilardoni MB; Tang Y; Pellizas CG; Yan L Histochem Cell Biol; 2008 Dec; 130(6):1155-64. PubMed ID: 18769934 [TBL] [Abstract][Full Text] [Related]
15. Expression of extracellular matrix metalloproteinase inducer (EMMPRIN/CD147) in pancreatic neoplasm and pancreatic stellate cells. Zhang W; Erkan M; Abiatari I; Giese NA; Felix K; Kayed H; Büchler MW; Friess H; Kleeff J Cancer Biol Ther; 2007 Feb; 6(2):218-27. PubMed ID: 17224648 [TBL] [Abstract][Full Text] [Related]
16. CD73 complexes with emmprin to regulate MMP-2 production from co-cultured sarcoma cells and fibroblasts. Aoki M; Koga K; Miyazaki M; Hamasaki M; Koshikawa N; Oyama M; Kozuka-Hata H; Seiki M; Toole BP; Nabeshima K BMC Cancer; 2019 Sep; 19(1):912. PubMed ID: 31510956 [TBL] [Abstract][Full Text] [Related]
17. Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas. Heimberger AB; McGary EC; Suki D; Ruiz M; Wang H; Fuller GN; Bar-Eli M Clin Cancer Res; 2005 Jan; 11(1):267-72. PubMed ID: 15671555 [TBL] [Abstract][Full Text] [Related]
18. Expression and clinical significance of CD147 in genitourinary carcinomas. Han ZD; He HC; Bi XC; Qin WJ; Dai QS; Zou J; Ye YK; Liang YX; Zeng GH; Zhu G; Chen ZN; Zhong WD J Surg Res; 2010 May; 160(2):260-7. PubMed ID: 19286191 [TBL] [Abstract][Full Text] [Related]
19. The value and correlation between PRL-3 expression and matrix metalloproteinase activity and expression in human gliomas. Kong L; Li Q; Wang L; Liu Z; Sun T Neuropathology; 2007 Dec; 27(6):516-21. PubMed ID: 18021371 [TBL] [Abstract][Full Text] [Related]
20. Direct cell-cell interaction enhances pro-MMP-2 production and activation in co-culture of laryngeal cancer cells and fibroblasts: involvement of EMMPRIN and MT1-MMP. Suzuki S; Sato M; Senoo H; Ishikawa K Exp Cell Res; 2004 Feb; 293(2):259-66. PubMed ID: 14729463 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]